Focus Partners Wealth Raises Position in The Cooper Companies, Inc. $COO

Focus Partners Wealth raised its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 39,754.6% during the 4th quarter, HoldingsChannel reports. The fund owned 1,294,080 shares of the medical device company’s stock after acquiring an additional 1,290,833 shares during the quarter. Focus Partners Wealth’s holdings in Cooper Companies were worth $106,063,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also modified their holdings of the company. Root Financial Partners LLC boosted its stake in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the last quarter. Bell Investment Advisors Inc boosted its stake in shares of Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC purchased a new position in shares of Cooper Companies during the 2nd quarter worth $36,000. True Wealth Design LLC boosted its stake in shares of Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after acquiring an additional 383 shares during the last quarter. Finally, Cromwell Holdings LLC boosted its stake in shares of Cooper Companies by 128.8% during the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after acquiring an additional 273 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

COO opened at $67.88 on Monday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The firm’s fifty day moving average is $64.79 and its 200 day moving average is $74.34. The stock has a market cap of $13.24 billion, a price-to-earnings ratio of 57.53, a price-to-earnings-growth ratio of 1.78 and a beta of 0.88.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the previous year, the company earned $0.96 EPS. Cooper Companies’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently weighed in on COO. Robert W. Baird dropped their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. Rothschild & Co Redburn cut shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a research note on Wednesday, March 4th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Citigroup restated a “neutral” rating and set a $69.00 target price (down from $80.00) on shares of Cooper Companies in a research note on Thursday, May 28th. Finally, Mizuho set a $85.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $82.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.